Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17256162 | PEPTIDE DEFICIENT-MHC CLASS I/CHAPERONE COMPOSITIONS AND METHODS | December 2020 | July 2023 | Allow | 30 | 2 | 0 | No | No |
| 17115291 | SYSTEMS AND METHODS OF EPITOPE BINNING AND ANTIBODY PROFILING | December 2020 | March 2023 | Abandon | 27 | 2 | 0 | Yes | No |
| 17058722 | LIGANDS AND METHODS OF SELECTING BINDING TARGETS FOR SUCH | November 2020 | December 2023 | Allow | 36 | 1 | 1 | No | No |
| 17083033 | LIBRARIES OF NUCLEIC ACIDS AND METHODS FOR MAKING THE SAME | October 2020 | July 2024 | Abandon | 44 | 2 | 1 | No | No |
| 17066167 | Fusion Proteins Comprising an Engineered Knottin Peptide and Uses Thereof | October 2020 | July 2022 | Allow | 21 | 1 | 0 | Yes | No |
| 17064311 | SINGLE CELL ANALYSIS USING SECONDARY ION MASS SPECTROMETRY | October 2020 | June 2024 | Allow | 45 | 2 | 0 | Yes | No |
| 17060354 | MICROFLUIDIC DEVICE FOR STORAGE AND WELL-DEFINED ARRANGEMENT OF DROPLETS | October 2020 | July 2022 | Allow | 21 | 2 | 0 | No | No |
| 17039490 | PROBE SET FOR ANALYZING A DNA SAMPLE AND METHOD FOR USING THE SAME | September 2020 | January 2023 | Allow | 27 | 1 | 0 | No | No |
| 17031260 | TARGET BINDING MOIETY COMPOSITIONS AND METHODS OF USE | September 2020 | October 2022 | Allow | 24 | 0 | 0 | Yes | No |
| 17019121 | Methods and Compositions for Protein and Peptide Sequencing | September 2020 | July 2023 | Allow | 35 | 0 | 1 | No | No |
| 17019084 | METHODS AND COMPOSITIONS FOR PROTEIN AND PEPTIDE SEQUENCING | September 2020 | November 2023 | Allow | 38 | 2 | 0 | Yes | No |
| 16977421 | GENERATION OF SINGLE-STRANDED CIRCULAR DNA TEMPLATES FOR SINGLE MOLECULE SEQUENCING | September 2020 | September 2023 | Allow | 37 | 0 | 0 | No | No |
| 16988696 | METHODS FOR IDENTIFYING SELECTIVE BINDING PAIRS | August 2020 | August 2022 | Allow | 25 | 0 | 0 | Yes | No |
| 16959583 | SELF-ASSEMBLING DIAGNOSTIC ARRAY PLATFORM | July 2020 | February 2024 | Abandon | 44 | 2 | 1 | Yes | No |
| 16906513 | COMPOSITIONS AND METHODS FOR QUANTITATIVE ASSESSMENT OF DNA-PROTEIN COMPLEX DENSITY | June 2020 | December 2023 | Allow | 42 | 2 | 1 | Yes | No |
| 16770871 | METHOD OF PRODUCING A VACCINE COMPOSITION AND USES THEREOF | June 2020 | June 2024 | Abandon | 48 | 1 | 0 | No | No |
| 16767727 | SELECTING FOR DEVELOPABILITY OF POLYPEPTIDE DRUGS IN EUKARYOTIC CELL DISPLAY SYSTEMS | May 2020 | April 2022 | Allow | 23 | 1 | 0 | No | No |
| 16875707 | DNAZYME-BASED SENSOR FOR HELICOBACTER PYLORI | May 2020 | September 2022 | Allow | 28 | 0 | 1 | Yes | No |
| 16760028 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | April 2020 | May 2022 | Allow | 24 | 2 | 0 | No | No |
| 16628481 | PIG GENOME-WIDE SPECIFIC SGRNA LIBRARY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | April 2020 | September 2023 | Allow | 45 | 1 | 1 | Yes | No |
| 16832990 | NANOPORE DEVICE AND METHODS OF BIOSYNTHESIS USING SAME | March 2020 | November 2022 | Allow | 32 | 0 | 0 | Yes | No |
| 16791456 | METHODS OF SELECTING BINDING REAGENTS | February 2020 | October 2023 | Allow | 44 | 4 | 2 | Yes | No |
| 16784962 | MUTANT SUBGENOMIC PROMOTER LIBRARY AND USES THEREOF | February 2020 | May 2024 | Allow | 51 | 4 | 1 | Yes | No |
| 16744002 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | January 2020 | March 2022 | Allow | 26 | 2 | 0 | No | No |
| 16624682 | OPTICAL SUPER-MULTIPLEXING BY POLYYNES | December 2019 | April 2024 | Allow | 52 | 4 | 1 | Yes | No |
| 16623186 | METHOD FOR QUANTIFYING PROTEIN COPY-NUMBER | December 2019 | March 2024 | Abandon | 51 | 0 | 1 | No | No |
| 16714745 | MODEL FOR HIGH-THROUGHPUT SCREENING OF ENDOCRINE DISRUPTOR AND METHOD FOR SCREENING SAME | December 2019 | April 2024 | Allow | 52 | 1 | 0 | No | No |
| 16620353 | METHODS FOR GENERATING SMALL MOLECULE DEGRADERS AND DIMERIZERS | December 2019 | August 2023 | Abandon | 45 | 2 | 1 | No | No |
| 16615914 | DEVICE AND METHOD FOR NUCLEIC ACID MANIPULATION | November 2019 | April 2023 | Abandon | 41 | 1 | 1 | No | No |
| 16607378 | MODIFICATION OF POLYPEPTIDES | October 2019 | November 2023 | Allow | 48 | 5 | 0 | Yes | No |
| 16605203 | Compositions and methods for library construction and sequence analysis | October 2019 | July 2023 | Allow | 45 | 1 | 2 | No | No |
| 16497684 | METHODS AND KITS FOR DETERMINING BINDING SITES | September 2019 | June 2023 | Allow | 45 | 1 | 1 | No | No |
| 16489099 | HEATED DEVICE FOR ARRAY SYNTHESIS | August 2019 | April 2024 | Abandon | 56 | 4 | 1 | No | Yes |
| 16482592 | SYSTEM AND METHOD WITH FIDUCIALS RESPONDING TO MULTIPLE EXCITATION FREQUENCIES | July 2019 | October 2023 | Allow | 50 | 2 | 1 | No | No |
| 16461648 | Elongate Solid Phase Body | May 2019 | August 2022 | Allow | 39 | 2 | 0 | No | No |
| 16402130 | Electrode Array Device Having an Adsorbed Porous Reaction Layer | May 2019 | March 2023 | Allow | 47 | 2 | 0 | Yes | No |
| 16339463 | CLASSIFICATION AND PROGNOSIS OF CANCER | April 2019 | March 2023 | Allow | 48 | 2 | 1 | Yes | No |
| 16352355 | Proteomics and Spatial Patterning Using Antenna Networks | March 2019 | July 2023 | Allow | 53 | 3 | 1 | No | No |
| 16333109 | METHODS AND COMPOSITIONS FOR T-CELL EPITOPE SCREENING | March 2019 | May 2024 | Allow | 60 | 2 | 2 | No | No |
| 16309056 | A NOVEL METABOLIC DISORDER TARGET | December 2018 | September 2022 | Allow | 46 | 1 | 1 | Yes | No |
| 16184513 | METHODS AND DEVICES FOR DETECTION OF PERIPHERAL MEMBRANE PROTEIN INTERACTIONS USING NONLINEAR OPTICAL TECHNIQUES | November 2018 | June 2022 | Allow | 43 | 1 | 0 | No | No |
| 16182508 | HIGH-THROUGHPUT HYBRIDIZATION AND READING METHOD FOR BIOCHIPS AND SYSTEM THEREOF | November 2018 | September 2022 | Allow | 47 | 3 | 0 | Yes | No |
| 16098436 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | November 2018 | March 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16090829 | MAMMALIAN CELL LINE FOR PROTEIN PRODUCTION AND LIBRARY GENERATION | October 2018 | May 2023 | Allow | 56 | 2 | 0 | Yes | No |
| 16141707 | DEVICE FOR ADDITIVE DELIVERY OF REAGENTS AND RELATED METHODS AND SYSTEMS | September 2018 | June 2024 | Allow | 60 | 6 | 1 | Yes | No |
| 16116432 | Mapping of Genomic Interactions | August 2018 | May 2022 | Allow | 44 | 1 | 1 | No | No |
| 16070505 | SEMI-PERMEABLE ARRAYS FOR ANALYZING BIOLOGICAL SYSTEMS AND METHODS OF USING SAME | July 2018 | April 2024 | Allow | 60 | 5 | 1 | Yes | No |
| 16034392 | Deep Sequencing Profiling of Tumors | July 2018 | January 2023 | Allow | 54 | 5 | 0 | No | No |
| 15958566 | METHODS FOR SELECTIVELY ANALYZING BIOLOGICAL SAMPLES | April 2018 | March 2023 | Abandon | 59 | 2 | 1 | No | No |
| 15933123 | METHOD OF QUANTIFYING PEPTIDE-DERIVATIVE LIBRARIES USING PHAGE DISPLAY | March 2018 | June 2022 | Allow | 51 | 2 | 0 | No | No |
| 15903506 | METHOD OF GENOME-WIDE DIRECT IDENTIFICATION OF ELECTROPHILE-SENSING TARGETS | February 2018 | July 2022 | Allow | 52 | 2 | 1 | Yes | No |
| 15848640 | ARRAYS INCLUDING A RESIN FILM AND A PATTERNED POLYMER LAYER | December 2017 | July 2022 | Allow | 54 | 1 | 2 | No | No |
| 15571220 | BROAD-SPECTRUM SEROLOGICAL DIAGNOSTICS AND USES THEREOF | November 2017 | January 2024 | Abandon | 60 | 6 | 1 | No | No |
| 15695536 | MHC-BOUND PEPTIDE ARRAYS AND METHODS OF USE THEREOF | September 2017 | October 2022 | Allow | 60 | 4 | 1 | No | No |
| 15512091 | Single-Molecule Phenotype Analysis | March 2017 | December 2022 | Allow | 60 | 5 | 1 | Yes | No |
| 15272004 | FLEXIBLE SUBSTRATES FOR NUCLEIC ACID SYNTHESIS | September 2016 | September 2022 | Allow | 60 | 3 | 1 | No | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GROSS, CHRISTOPHER M.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner GROSS, CHRISTOPHER M works in Art Unit 1675 and has examined 56 patent applications in our dataset. With an allowance rate of 82.1%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 45 months.
Examiner GROSS, CHRISTOPHER M's allowance rate of 82.1% places them in the 56% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by GROSS, CHRISTOPHER M receive 2.14 office actions before reaching final disposition. This places the examiner in the 54% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by GROSS, CHRISTOPHER M is 45 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +17.8% benefit to allowance rate for applications examined by GROSS, CHRISTOPHER M. This interview benefit is in the 58% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 28.2% of applications are subsequently allowed. This success rate is in the 53% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 38.9% of cases where such amendments are filed. This entry rate is in the 60% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 1% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 87% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 83.3% are granted (fully or in part). This grant rate is in the 85% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 21.7% of allowed cases (in the 95% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.